- Rating
- 2
- Confidence
- 2
- Informativeness
- 3
- Presentation
- 3
- Soundness
- 2
Read review
Paper summary
This paper proposes PepGuide, a target-conditioned peptide design framework combining a geometry-aware contrastive VAE, an interaction-aware network (IANet), and latent diffusion. IANet is trained to predict Rosetta binding energies from peptide–target complexes. Its interaction features are mapped to a coordinate-space guidance signal, which is injected into the diffusion process according to a time-dependent schedule. At inference, the signal is estimated from an unguided reference peptide selected by VAE perplexity. The authors report results on BioDB and the external LNR benchmark, evaluate multiple binding and structural metrics, and include component and guidance-schedule ablations, a multi-pocket Trop2 study, and an MD analysis on one target.
Critical strengths
-
The paper addresses a meaningful limitation of target-conditioned peptide generation. PepGuide attempts to translate peptide–target interface information into an explicit signal used during generation, rather than relying only on global target conditioning. The ablation results suggest that both the guidance component and contrastive representation learning contribute to the reported metrics.
-
The evaluation includes multiple complementary analyses. In addition to sequence and structural metrics, the authors report DockQ and alternative energy scores, compare guidance schedules, and analyze a 50-ns MD trajectory for one target. They also acknowledge that computational evaluation does not replace experimental validation.
Critical weaknesses
-
The training procedure for the central coordinate-guidance head is not specified clearly enough to reproduce or assess the main mechanism. Section 3.3 defines the guidance signal as , where maps IANet features to per-residue coordinate offsets. However, the paper does not state what objective trains , whether it is optimized jointly, or whether gradients from the latent-diffusion loss pass through the guided forward process into . Equation 9 specifies a noise-prediction loss. Appendix F.2, Algorithm 3 freezes the VAE and IANet, initializes the denoiser , and updates ; it does not say whether is included in , updated separately, or fixed. This ambiguity concerns the mechanism at the center of the contribution.
-
The independence of the external evaluation and the interpretation of “binding success” need clarification. BioDB is assembled from PepBDB and Q-BioLiP, while LNR is presented as an external test set. The paper describes de-duplication within BioDB and receptor clustering for its internal split, but does not report a cross-source overlap check between LNR and BioDB training data. A PDB-ID overlap check, together with receptor-cluster overlap information, would clarify whether LNR is independent of training. In addition, IANet is trained using Rosetta energy, while the SR column in Table 1 and the Trop2 SR in Table 2 use Rosetta-based criteria. The MD analysis in Appendix E.1 also selects the lowest-Rosetta-energy candidate for each method. DockQ and alternative energy metrics provide useful complementary evidence, but the reported success rates should be interpreted as computational scoring success unless supported by independent evidence.
Questions for authors
Q1: How is , the MLP mapping IANet features to coordinate guidance, optimized? Is included in the optimizer update for Algorithm 3, and does the gradient from flow through into ? If it is trained separately or fixed, what objective or initialization produces the coordinate-aligned signal?
Q2: Can the authors report the cross-source overlap check for LNR? In particular, were LNR PDB entries or receptor clusters removed from BioDB training? A PDB-ID overlap check and receptor-sequence/cluster comparison would directly address whether the LNR results support external generalization. Please also clarify that SR in Table 1 and the Trop2 SR in Table 2 are defined by the Rosetta criterion.